Alexion Pharm Inc (ALXN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 710,198 | 1,010,000 | 1,163,281 | 1,322,123 | 916,814 |
| Marketable Securities | 317,354 | 375,000 | 295,211 | 172,229 | 1,008,278 |
| Receivables | 586,249 | 533,000 | 512,253 | 535,824 | 479,883 |
| Inventories | 293,962 | 290,000 | 236,542 | 234,347 | 174,498 |
| TOTAL | $2,127,509 | $2,416,000 | $2,480,219 | $2,533,238 | $2,852,987 |
| Non-Current Assets | |||||
| PPE Net | 749,295 | 697,000 | 618,733 | 555,388 | 440,487 |
| Intangibles | 9,677,138 | 9,756,000 | 9,803,420 | 9,831,662 | 841,108 |
| Other Non-Current Assets | 248,507 | 228,000 | 250,647 | 247,430 | 280,343 |
| TOTAL | $10,674,940 | $10,681,000 | $10,672,800 | $10,634,480 | $1,561,938 |
| Total Assets | $12,802,450 | $13,097,000 | $13,153,010 | $13,167,720 | $4,414,925 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 35,358 | 166,000 | 175,000 | 131,250 | 45,500 |
| Accounts payable and accrued liabilities | 42,897 | 57,000 | 46,974 | 47,039 | 52,869 |
| Accrued Expenses | 359,077 | 403,000 | 357,987 | 407,345 | 308,407 |
| Other current liabilities | 87,865 | 6,000 | 4,336 | 53,151 | 67,047 |
| TOTAL | $603,613 | $709,000 | $766,860 | $769,169 | $580,439 |
| Non-Current Liabilities | |||||
| Long Term Debt | 3,212,772 | 3,254,000 | 3,325,000 | 3,368,750 | N/A |
| Deferred Revenues | 78,416 | 21,000 | 49,944 | 88,366 | 106,616 |
| aiOther Non-Current Liabilities | 214,903 | 195,000 | 241,363 | 347,369 | 202,672 |
| TOTAL | $4,136,555 | $4,129,000 | $4,133,286 | $3,845,679 | $317,584 |
| Total Liabilities | $4,740,168 | $4,838,000 | $4,900,146 | $4,614,848 | $898,023 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 224,020 | 225,291 | 225,324 | 226,155 | 199,577 |
| Common Shares | 23 | N/A | 23 | 23 | 20 |
| Retained earnings | 1,272,561 | 1,181,000 | 1,113,791 | 1,297,548 | 1,127,333 |
| Other shareholders' equity | 3,637 | 62,000 | 54,081 | 62,989 | 119,499 |
| TOTAL | $8,062,277 | $8,259,000 | $8,252,869 | $8,552,871 | $3,516,902 |
| Total Liabilities And Equity | $12,802,445 | $13,097,000 | $13,153,015 | $13,167,719 | $4,414,925 |